Guidant Cites Ethics In Countering Drug-Eluting Stent Data Enjoinment
This article was originally published in The Gray Sheet
Guidant is relying on two ethical arguments to persuade a federal judge not to block access to clinical drug-eluting stent data collected in collaboration with Cook, Inc
You may also be interested in...
Guidant's $3 bil. purchase of Cook Group does not represent a "change of ownership" under the terms of a 1997 licensing agreement between subsidiary Cook, Inc., Angiotech Pharmaceuticals and Boston Scientific, Guidant asserts
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.